The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Inhibition of Elevated Ca2+/Calmodulin-Dependent Protein Kinase II Improves Contractility in Human Failing Myocardium
Open accessAbstract
Rationale: Heart failure (HF) is known to be associated with increased Ca 2+/calmodulin-dependent protein kinase (CaMK)II expression and activity. There is still controversial discussion about the functional role of CaMKII in HF. Moreover, CaMKII inhibition has never been investigated in human myocardium. Objective: We sought to investigate detailed CaMKIIδ expression in end-stage failing human hearts (dilated and ischemic cardiomyopathy) and the functional effects of CaMKII inhibition on contractility. Methods and Results: Expression analysis revealed that CaMKIIδ, both cytosolic δ C and nuclear δ B splice variants, were significantly increased in both right and left ventricles from patients with dilated or ischemic cardiomyopathy versus nonfailing. Experiments with isometrically twitching trabeculae revealed significantly improved force frequency relationships in the presence of CaMKII inhibitors (KN-93 and AIP). Increased postrest twitches after CaMKII inhibition indicated an improved sarcoplasmic reticulum (SR) Ca 2+loading. This was confirmed in isolated myocytes by a reduced SR Ca 2+spark frequency and hence SR Ca 2+leak, resulting in increased SR Ca 2+load when inhibiting CaMKII. Ryanodine receptor type 2 phosphorylation at Ser2815, which is known to be phosphorylated by CaMKII thereby contributing to SR Ca 2+leak, was found to be markedly reduced in KN-93–treated trabeculae. Interestingly, CaMKII inhibition did not influence contractility in nonfailing sheep trabeculae. Conclusions: The present study shows for the first time that CaMKII inhibition acutely improves contractility in human HF where CaMKIIδ expression is increased. The mechanism proposed consists of a reduced SR Ca 2+leak and consequently increased SR Ca 2+load. Thus, CaMKII inhibition appears to be a possible therapeutic option for patients with HF and merits further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Note that the trabeculae from Sossalla et al. 2010 were in presence of KN-92, an inactive analogue of the CaMKII inhibitor KN-93.”
From Small and large animal models in cardiac contraction research: advantages and disadvantages (2014) · cites this paper as Sossalla, et al., 2010
In the citing paper
“Increasing stimulation frequency in sheep trabeculae from 0.5 Hz to 2 Hz resulted in a 139–171% increase in force production (Schotola, et al., 2011; Sossalla, et al., 2010).”
From Small and large animal models in cardiac contraction research: advantages and disadvantages (2014) · cites this paper as Sossalla, et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hasenfuss, G. P., Reinecke, H., Studer, R., Meyer, M., Pieske, B. M., Holtz, J., Holubarsch, C., Posival, H., Just, H., & Drexler, H. (1994) · Circulation Research · doi:10.1161/01.res.75.3.434 · Cited by 781
Self-citationAi, X., Curran, J. W., Shannon, T. R., Bers, D. M., & Pogwizd, S. M. (2005) · Circulation Research · doi:10.1161/01.res.0000194329.41863.89 · Cited by 698
JBeuckelmann, D., MNäbauer, & EErdmann (1992) · Circulation · Cited by 662
Beuckelmann, D. J., Näbauer, M., & Erdmann, E. (1992) · Circulation · doi:10.1161/01.cir.85.3.1046 · Cited by 636
Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure.
Studer, R., Reinecke, H., Bilger, J., Thomas Eschenhagen, A., Böhm, M., Hasenfuss, G. P., Just, H., Holtz, J., & Drexler, H. (1994) · Circulation Research · doi:10.1161/01.res.75.3.443 · Cited by 633
Self-citationWehrens, X. H. T., Lehnart, S. E., Reiken, S. R., & Marks, A. R. (2004) · Circulation Research · doi:10.1161/01.res.0000125626.33738.e2 · Cited by 622
Calmodulin kinase II inhibition protects against structural heart disease
Zhang, R., Khoo, M. S. C., Wu, Y., Yang, Y., Grueter, C. E., Ni, G., Price, E., Thiel, W. H., Guatimosim, S., Song, L., et al. (2005) · Nature Medicine · doi:10.1038/nm1215 · Cited by 580
Zhang, T., Maier, L. S., Dalton, N. D., Miyamoto, S., Ross, J., Bers, D. M., & Brown, J. H. (2003) · Circulation Research · doi:10.1161/01.res.0000069686.31472.c5 · Cited by 560
Self-citationUnique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity
Witcher, D. R., Kovacs, R. J., Schulman, H., Cefali, D. C., & Jones, L. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99140-4 · Cited by 503
Transgenic CaMKIIδ C Overexpression Uniquely Alters Cardiac Myocyte Ca 2+ Handling
Maier, L. S., Zhang, T., Chen, L., DeSantiago, J., Brown, J. H., & Bers, D. M. (2003) · Circulation Research · doi:10.1161/01.res.0000069685.20258.f1 · Cited by 433
Self-citation
Cited by
Sorted by citations
Small and large animal models in cardiac contraction research: advantages and disadvantages
Milani-Nejad, N., & Janssen, P. M. L. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.007 · Cited by 484
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433
Mechanisms of Altered Ca 2+ Handling in Heart Failure
Luo, M., & Anderson, M. E. (2013) · Circulation Research · doi:10.1161/circresaha.113.301651 · Cited by 392
van Oort, R. J., McCauley, M. D., Dixit, S. S., Pereira, L., Yang, Y., Respress, J. L., Wang, Q., Almeida, A. C. D., Skapura, D. G., Anderson, M. E., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.982298 · Cited by 310
Calmodulin-Dependent Protein Kinase II: Linking Heart Failure and Arrhythmias
Dominic, P. S., Purohit, A., Hund, T. J., & Anderson, M. E. (2012) · Circulation Research · doi:10.1161/circresaha.111.243956 · Cited by 296
Calcium Signaling and Transcriptional Regulation in Cardiomyocytes
Dewenter, M., von der Lieth, A., Katus, H. A., & Backs, J. (2017) · Circulation Research · doi:10.1161/circresaha.117.310355 · Cited by 260
Empagliflozin directly improves diastolic function in human heart failure
Pabel, S., Wagner, S., Bollenberg, H., Bengel, P., Kovács, Á., Schach, C., Tirilomis, P., Mustroph, J., Renner, A., Gummert, J., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1328 · Cited by 224
Self-citationWang, Y., Liu, X., Shi, H., Yu, Y. Q., Yu, Y., Li, M., & Chen, R. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.13 · Cited by 208
Hamdani, N., Krysiak, J., Kreußer, M. M., Neef, S., dos Remedios, C. G., Maier, L. S., Krüger, M., Backs, J., & Linke, W. A. (2013) · Circulation Research · doi:10.1161/circresaha.111.300105 · Cited by 186
Self-citationAltered sarcoplasmic reticulum calcium cycling—targets for heart failure therapy
Kho, C., Lee, A., & Hajjar, R. J. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.145 · Cited by 177
Fischer, T. H., Herting, J., Tirilomis, T., Renner, A., Neef, S., Toischer, K., Ellenberger, D., Förster, A., Schmitto, J. D., Gummert, J. F., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001746 · Cited by 158
Self-citationSag, C. M., Köhler, A. C., Anderson, M. E., Backs, J., & Maier, L. S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.07.016 · Cited by 139
Self-citationNovel therapeutic targets for the treatment of heart failure
Tamargo, J. L., & Lopez-Sendon, J. L. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3431 · Cited by 133
CaMKII as a Therapeutic Target in Cardiovascular Disease
Gaido, O. E. R., Nkashama, L. J., Schole, K. L., Wang, Q., Umapathi, P., Mesubi, O. O., Konstantinidis, K., Luczak, E. D., & Anderson, M. E. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051421-111814 · Cited by 129
SGLT2 Inhibitors and Their Mode of Action in Heart Failure—Has the Mystery Been Unravelled?
Pabel, S., Hamdani, N., Luedde, M., & Sossalla, S. T. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00529-8 · Cited by 142
Self-citationRemodeling of Calcium Handling in Human Heart Failure
Lou, Q., Janardhan, A. H., & Efimov, I. R. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2888-2_52 · Cited by 123
Sanchez‐Alonso, J. L., Bhargava, A., O’Hara, T., Glukhov, A. V., Schobesberger, S., Bhogal, N., Sikkel, M. B., Mansfield, C. A., Korchev, Y. E., Lyon, A. R., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308698 · Cited by 121
Targeting Cardiomyocyte Ca2+ Homeostasis in Heart Failure
Røe, Å. T., Frisk, M., & Louch, W. E. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282104141204124129 · Cited by 110
New Therapeutic Targets in Cardiology
Rokita, A. G., & Anderson, M. E. (2012) · Circulation · doi:10.1161/circulationaha.112.124990 · Cited by 117
Zhang, J., Liang, R., Wang, K., Zhang, W., Zhang, M., Jin, L., Xie, P., Zheng, W., Shang, H., Hu, Q., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.055920 · Cited by 105
Role of oxidants on calcium and sodium movement in healthy and diseased cardiac myocytes
Sag, C. M., Wagner, S., & Maier, L. S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.035 · Cited by 112
Self-citationToischer, K., Hartmann, N., Wagner, S., Fischer, T. H., Herting, J., Danner, B. C., Sag, C. M., Hund, T. J., Mohler, P. J., Belardinelli, L., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.03.021 · Cited by 104
Self-citationRole of ranolazine in angina, heart failure, arrhythmias, and diabetes
Sossalla, S. T., & Maier, L. S. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.11.003 · Cited by 104
Self-citationSuetomi, T., Miyamoto, S., & Brown, J. H. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00223.2019 · Cited by 105
CaMKII as a target for arrhythmia suppression
Mustroph, J., Neef, S., & Maier, L. S. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.006 · Cited by 100
Self-citationNav1.5-dependent persistent Na+ influx activates CaMKII in rat ventricular myocytes and N1325S mice
Yao, L., Fan, P., Jiang, Z., Viatchenko‐Karpinski, S., Wu, Y., Kornyeyev, D., Hirakawa, R., Budas, G. R., Rajamani, S., Shryock, J. C., et al. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00125.2011 · Cited by 96
Posttranslational modifications of cardiac ryanodine receptors: Ca2+ signaling and EC-coupling
Niggli, E., Ullrich, N. D., Gutierrez, D. A., Kyrychenko, S., Polaková, E., & Shirokova, N. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.016 · Cited by 99
Mitochondrial CaMKII causes adverse metabolic reprogramming and dilated cardiomyopathy
Luczak, E. D., Wu, Y., Granger, J. M., Joiner, M.-L. A., Wilson, N. R., Gupta, A. K., Umapathi, P., Murphy, K. R., Gaido, O. E. R., Sabet, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18165-6 · Cited by 96
Ca handling during excitation–contraction coupling in heart failure
Zima, A. V., Bovo, E., Mazurek, S. R., Rochira, J. A., Li, W., & Terentyev, D. A. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1469-3 · Cited by 92
Sossalla, S. T., Maurer, U., Schotola, H., Hartmann, N., Didié, M., Zimmermann, W., Jacobshagen, C., Wagner, S., & Maier, L. S. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0136-x · Cited by 92
Self-citationHegyi, B., Pölönen, R.-P., Hellgren, K. T., Ko, C. Y., Ginsburg, K. S., Bossuyt, J., Mercola, M. A., & Bers, D. M. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00900-9 · Cited by 92
Effects of Atrial Fibrillation on the Human Ventricle
Pabel, S., Knierim, M., Stehle, T., Alebrand, F., Paulus, M., Sieme, M., Herwig, M., Barsch, F., Körtl, T., Pöppl, A., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.319718 · Cited by 89
Self-citationReactive oxygen species and excitation–contraction coupling in the context of cardiac pathology
Köhler, A. C., Sag, C. M., & Maier, L. S. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.03.001 · Cited by 89
Self-citationCalcium‐mediated cellular triggered activity in atrial fibrillation
Dobrev, D., & Wehrens, X. H. T. (2017) · The Journal of Physiology · doi:10.1113/jp273048 · Cited by 84
Arrhythmogenic Mechanisms in Heart Failure: Linking β-Adrenergic Stimulation, Stretch, and Calcium
Johnson, D. M., & Antoons, G. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01453 · Cited by 84
No Rest for the Weary: Diastolic Calcium Homeostasis in the Normal and Failing Myocardium
Louch, W. E., Stokke, M. K., Sjaastad, I., Christensen, G., & Sejersted, O. M. (2012) · Physiology · doi:10.1152/physiol.00021.2012 · Cited by 82
Grimm, M. F., Ling, H., Willeford, A., Pereira, L., Gray, C. B. B., Erickson, J. R., Sarma, S., Respress, J. L., Wehrens, X. H. T., Bers, D. M., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.06.007 · Cited by 81
Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal
Mesubi, O. O., & Anderson, M. E. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw002 · Cited by 81
CaMKII regulation of cardiac ryanodine receptors and inositol triphosphate receptors
Camors, E. M., & Valdivia, H. H. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00101 · Cited by 80
‘Ryanopathy’: causes and manifestations of RyR2 dysfunction in heart failure
Belevych, A. E., Radwański, P., Carnes, C. A., & Györke, S. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt024 · Cited by 74
Improvement of cardiomyocyte function by a novel pyrimidine-based CaMKII-inhibitor
Neef, S., Steffens, A., Pellicena, P., Mustroph, J., Lebek, S., Ort, K. R., Schulman, H., & Maier, L. S. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.12.015 · Cited by 74
Self-citationMild metabolic acidosis impairs the β-adrenergic response in isolated human failing myocardium
Schotola, H., Toischer, K., Popov, A., Renner, A., Schmitto, J. D., Gummert, J. F., Quintel, M., Bauer, M., Maier, L. S., & Sossalla, S. T. (2012) · Critical Care · doi:10.1186/cc11468 · Cited by 73
Self-citationAntiarrhythmic effects of dantrolene in human diseased cardiomyocytes
Hartmann, N., Pabel, S., Herting, J., Schatter, F., Renner, A., Gummert, J. F., Schotola, H., Danner, B. C., Maier, L. S., Frey, N., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.09.014 · Cited by 71
Self-citationDries, E., Santiago, D. J., Gilbert, G., Lenaerts, I., Vandenberk, B., Nagaraju, C. K., Johnson, D. M., Holemans, P., Roderick, H. L., Macquaide, N., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy088 · Cited by 68
Lebek, S., Pichler, K., Reuthner, K., Trum, M., Tafelmeier, M., Mustroph, J., Camboni, D., Rupprecht, L., Schmid, Ç., Maier, L. S., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.315755 · Cited by 70
Self-citationFischer, T. H., Eiringhaus, J., Dybkova, N., Förster, A., Herting, J., Kleinwächter, A., Ljubojević-Holzer, S., Schmitto, J. D., Streckfuß‐Bömeke, K., Renner, A., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.163 · Cited by 66
Self-citationAntoons, G., Willems, R., & Sipido, K. R. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.12.001 · Cited by 65
Jung, G., Fajardo, G., Ribeiro, A. J. S., Kooiker, K. B., Coronado, M. J., Zhao, M., Hu, D., Reddy, S., Kodo, K., Sriram, K., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-280982 · Cited by 66
Regulation of CaMKII signaling in cardiovascular disease
Mollova, M. Y., Katus, H. A., & Backs, J. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00178 · Cited by 60
Daniels, L. J., Wallace, R. S., Nicholson, O. M., Wilson, G. A., McDonald, F. J., Jones, P. P., Baldi, J. C., Lamberts, R. R., & Erickson, J. R. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0732-x · Cited by 55
CaMKIIδC Drives Early Adaptive Ca 2+ Change and Late Eccentric Cardiac Hypertrophy
Ljubojević-Holzer, S., Herren, A. W., Djalinac, N., Voglhuber, J., Morotti, S., Holzer, M., Wood, B. M., Abdellatif, M., Matzer, I., Sacherer, M., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316947 · Cited by 58
Self-citationHamilton, S., & Terentyev, D. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01517 · Cited by 57
Lebek, S., Plößl, A., Baier, M. J., Mustroph, J., Tarnowski, D., Lücht, C. M., Schopka, S., Flörchinger, B., Schmid, C., Zausig, Y. A., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.03.020 · Cited by 55
Self-citationBeauverger, P., Ozoux, M., Bégis, G., Glénat, V., Briand, V., Philippo, M.-C., Daveu, C., Tavares, G., Roy, S. N., Corbier, A., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz097 · Cited by 53
SERCA2a gene therapy in heart failure: an anti‐arrhythmic positive inotrope
Sikkel, M. B., Hayward, C., MacLeod, K. T., Harding, S. E., & Lyon, A. R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12472 · Cited by 52
Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction
Budde, H., Hassoun, R., Mügge, A., Kov́acs, Á., & Hamdani, N. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.928232 · Cited by 56
Novel therapies in acute and chronic heart failure
Aronson, D., & Krum, H. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.03.002 · Cited by 51
Ionizing radiation regulates cardiac Ca handling via increased ROS and activated CaMKII
Sag, C. M., Wolff, H. A., Neumann, K., Opiela, M.-K., Zhang, J., Steuer, F., Sowa, T., Gupta, S. N., Schirmer, M., Hünlich, M., et al. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0385-6 · Cited by 50
Self-citationEnhanced late INa induces proarrhythmogenic SR Ca leak in a CaMKII-dependent manner
Sag, C. M., Mallwitz, A., Wagner, S., Hartmann, N., Schotola, H., Fischer, T. H., Ungeheuer, N., Herting, J., Shah, A. M., Maier, L. S., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.08.016 · Cited by 49
Self-citationPhosphatase-1 inhibitor-1 in physiological and pathological -adrenoceptor signalling
Wittköpper, K., Dobrev, D., Eschenhagen, T., & El‐Armouche, A. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr058 · Cited by 50
Self-citationHaworth, R. S., Σταθοπούλου, Κ., Candasamy, A. J., & Avkiran, M. (2012) · Circulation Research · doi:10.1161/circresaha.111.263665 · Cited by 48
Novel aspects of excitation–contraction coupling in heart failure
Neef, S., & Maier, L. S. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0360-2 · Cited by 47
Self-citationThe late Na current as a therapeutic target: Where are we?
Maier, L. S., & Sossalla, S. T. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.03.001 · Cited by 45
Self-citationHøydal, M. A., Kirkeby‐Garstad, I., Karevold, A., Wiseth, R., Haaverstad, R., Wahba, A., Stølen, T., Contu, R., Condorelli, G., Ellingsen, Ø., et al. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12271 · Cited by 46
Sarcoplasmic reticulum calcium leak contributes to arrhythmia but not to heart failure progression
Mohamed, B. A., Hartmann, N., Tirilomis, P., Sekeres, K., Li, W., Neef, S., Richter, C., Zeisberg, E. M., Kattner, L., Didié, M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan0724 · Cited by 46
Self-citationCurrie, S., Elliott, E. B., Smith, G. L., & Loughrey, C. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.02.006 · Cited by 45
Gene therapy for inherited arrhythmias
Bezzerides, V. J., Prondzynski, M., Carrier, L., & Pu, W. T. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa107 · Cited by 45
Herren, A. W., Weber, D. M., Rigor, R. R., Margulies, K. B., Phinney, B. S., & Bers, D. M. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00107 · Cited by 44
Dries, E., Bito, V., Lenaerts, I., Antoons, G., Sipido, K. R., & Macquaide, N. (2013) · Circulation Research · doi:10.1161/circresaha.113.301896 · Cited by 43
Is CaMKII a link between inflammation and hypertrophy in heart?
Singh, M. V., & Anderson, M. E. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0727-5 · Cited by 42
Gao, X., Wu, X., Yan, J., Zhang, J., Zhao, W., DeMarco, D. M., Zhang, Y., Bakhos, M., Mignery, G. A., Sun, J., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy011 · Cited by 41
Atrioventricular node ablation for atrial fibrillation in the era of conduction system pacing
Joza, J. E., Burri, H., Andrade, J. G., Linz, D., Ellenbogen, K. A., & Vernooy, K. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae656 · Cited by 40
The calcium–frequency response in the rat ventricular myocyte: an experimental and modelling study
Gattoni, S., Røe, Å. T., Frisk, M., Louch, W. E., Niederer, S., & Smith, N. P. (2016) · The Journal of Physiology · doi:10.1113/jp272011 · Cited by 40
Regulation of sarcoplasmic reticulum Ca2+ release by serine-threonine phosphatases in the heart
Terentyev, D. A., & Hamilton, S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.08.020 · Cited by 42
van Opbergen, C. J. M., Delmar, M., & van Veen, T. A. B. (2017) · Netherlands Heart Journal · doi:10.1007/s12471-017-0946-7 · Cited by 41
The role of CaMKII in diabetic heart dysfunction
Daniels, L. J., Bell, J. R., Delbridge, L. M. D., McDonald, F. J., Lamberts, R. R., & Erickson, J. R. (2015) · Heart Failure Reviews · doi:10.1007/s10741-015-9498-3 · Cited by 38
Neef, S., Mann, C., Zwenger, A., Dybkova, N., & Maier, L. S. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0637-y · Cited by 39
Self-citationValverde, C. A., Mazzocchi, G., Carlo, M. N. D., Pardo, A. C., Salas, N., Ragone, M. I., Felice, J. I., Cely-Ortiz, A., Consolini, A. E., Portiansky, E. L., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy213 · Cited by 39
The ryanodine receptor leak: how a tattered receptor plunges the failing heart into crisis
Fischer, T. H., Maier, L. S., & Sossalla, S. T. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9339-6 · Cited by 38
Self-citationCaMKII: The molecular villain that aggravates cardiovascular disease
Zhang, P. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4034 · Cited by 38
Mustroph, J., Wagemann, O., Lebek, S., Tarnowski, D., Ackermann, J., Drzymalski, M. A., Pabel, S., Schmid, Ç., Wagner, S., Sossalla, S. T., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.02.002 · Cited by 38
Self-citationMyocardial Energy Stress, Autophagy Induction, and Cardiomyocyte Functional Responses
Daniels, L. J., Varma, U., Annandale, M., Chan, E., Mellor, K. M., & Delbridge, L. M. D. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7650 · Cited by 38
Fischer, T. H., Eiringhaus, J., Dybkova, N., Saadatmand, A., Pabel, S., Weber, S., Wang, Y., Köhn, M., Tirilomis, T., Ljubojević-Holzer, S., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1297 · Cited by 39
Self-citationElectrical storm: recent pathophysiological insights and therapeutic consequences
Tsuji, Y., Heijman, J., Nattel, S., & Dobrev, D. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0336-2 · Cited by 38
Shahin, R. O., & Taha, M. O. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.10.071 · Cited by 35
Cardiac CaMKII activation promotes rapid translocation to its extra-dyadic targets
Wood, B. M., Simon, M., Galice, S., Alim, C. C., Ferrero, M., Pinna, N. N., Bers, D. M., & Bossuyt, J. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.10.010 · Cited by 35
Usui, T., Okada, M., Hara, Y., & Yamawaki, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.120 · Cited by 33
Polaková, E., Illaste, A., Ernst Niggli, A., & Sobie, E. A. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.278051 · Cited by 31
Mustroph, J., Drzymalski, M. A., Baier, M. J., Pabel, S., Biedermann, A., Memmel, B., Durczok, M., Neef, S., Sag, C. M., Floerchinger, B., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12895 · Cited by 31
Self-citation14-3-3 binding creates a memory of kinase action by stabilizing the modified state of phospholamban
Menzel, J., Kownatzki-Danger, D., Tokar, S., Ballone, A., Unthan‐Fechner, K., Kilisch, M., Lenz, C., Urlaub, H., Mori, M., Ottmann, C., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aaz1436 · Cited by 31
Gedefaw, L., Ullah, S., Leung, P. H. M., Cai, Y., Yip, S. P., & Huang, C. (2021) · Cells · doi:10.3390/cells10040916 · Cited by 31
Huke, S., DeSantiago, J., Kaetzel, M. A., Mishra, S., Brown, J. H., Dedman, J. R., & Bers, D. M. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.014 · Cited by 30
Ho, H., Belevych, A. E., Liu, B., Bonilla, I. M., Radwański, P., Kubasov, I. V., Valdivia, H. H., Schober, K. E., Carnes, C. A., & Györke, S. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07666 · Cited by 30
Sanchez‐Alonso, J. L., Loucks, A., Schobesberger, S., van Cromvoirt, A. M., Poulet, C. E., Chowdhury, R. A., Trayanova, N. A., & Gorelik, J. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102845 · Cited by 29
Differences in MEF2 and NFAT Transcriptional Pathways According to Human Heart Failure Aetiology
Cortés, R., Rivera, M., Roselló‐Lletí, E., Martínez‐Dolz, L., Bonet, L. A., Azorı́n, I., Lago, F., González‐Juanatey, J. R., & Portolés, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030915 · Cited by 29
CaMKII Inhibition in Heart Failure Makes Jump to Human
Bers, D. M. (2010) · Circulation Research · doi:10.1161/circresaha.110.231902 · Cited by 29
Cardioprotective Effects of Semaglutide on Isolated Human Ventricular Myocardium
Krammer, T., Baier, M. J., Hegner, P., Zschiedrich, T., Lukas, D., Wolf, M., Phu, C. L., Lutz, V., Evert, K., Kozakov, K., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3644 · Cited by 28
Self-citationAiba, T., Barth, A. S., Hesketh, G. G., Hashambhoy, Y. L., Chakir, K., Tunin, R. S., Greenstein, J. L., Winslow, R. L., Kass, D. A., & Tomaselli, G. F. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000400 · Cited by 28
Chronic CaMKII inhibition reverses cardiac function and cardiac reserve in HF mice
He, Q., Cheng, J., & Wang, Y. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.01.010 · Cited by 28
Bengel, P., Dybkova, N., Tirilomis, P., Ahmad, S., Hartmann, N., Mohamed, B. A., Krekeler, M. C., Maurer, W., Pabel, S., Trum, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26690-1 · Cited by 28
Self-citation
Metadata
- Authors
- Sossalla, S., Fluschnik, N., Schotola, H., Ort, K. R., Neef, S., Schulte, T., Wittköpper, K., Renner, A., Schmitto, J. D., Gummert, J., El-Armouche, A., Hasenfuss, G., & Maier, L. S.
- Affiliations
- Brigham and Women's Hospital (US)
- From the Departments of Cardiology and Pneumology (S.S., N.F., K.R.O., S.N., T.S., G.H., L.S.M.), Anesthesiology (H.S.), Pharmacology (K.W., A.E.-A.), Georg-August-University Göttingen, Germany; Department of Cardiovascular Surgery (A.R., J.G.), Heart and Diabetes Center, Bad Oeynhausen, Germany; and Division of Cardiac Surgery (J.D.S.), Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.
- ORCID
- Venue
- Circulation Research
- Published
- 2010-10-29
- Volume
- 107
- Issue
- 9
- Pages
- 1150-1161
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2159995809
- Cited by
- 237
- References
- 35
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 7 · 2023: 7 · 2022: 11 · 2021: 15 · 2020: 18 · 2019: 9 · 2018: 17 · 2017: 13 · 2016: 18 · 2015: 16 · 2014: 17 · 2013: 21 · 2012: 25
- FWCI
- 16.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- GRO (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- CaMKII, heart failure, cardiomyocyte contractility, dilated cardiomyopathy, ischemic cardiomyopathy, sarcoplasmic reticulum Ca2+ leak, ryanodine receptor phosphorylation, KN-93, AIP, force-frequency relationship
- MeSH terms
- Animals, Cells, Cultured, Heart Failure, Humans, Myocardial Contraction, Myocardium, Sheep, Protein Kinase Inhibitors, Calcium-Calmodulin-Dependent Protein Kinase Type 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
